Protect Yourself While There’s Still Time …

The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.

4 simple steps to protect your privacy and money before it’s too late.

James George Robinson net worth and biography

James Robinson Biography and Net Worth

Director of Nymox Pharmaceutical

James Robinson is an independent director of Nymox Pharmaceutical Corporation, a company that specializes in research and development of therapeutics and diagnostics, with an emphasis on products targeted to the rapidly aging male population in developed economies. Robinson has been a member of Nymox’s board of directors since 2015.

He is also the founder, chairman and CEO of Morgan Creek Entertainment, a leading independent film production company. During his tenure, Morgan Creek has produced an array of successful, critically-acclaimed feature films, including “Ace Ventura: Pet Detective,” “True Romance,” and “Robin Hood: Prince of Thieves.”

Before his career in film production took off, Robinson had an array of work experiences, including a stint in the Army, professional photography, and a car cleaning business. In 1975, he purchased a failing Subaru distributorship and managed to turn it around to the point that when he sold it in 1988, the company was distributing to 94 dealers throughout the Midwest.

He entered the film industry in 1979 at the suggestion of an attorney friend from Los Angeles. He worked in development and finance and had his first production credit in the 1984 film, “The Stone Boy.” In 1988, he formed Morgan Creek Productions (rebranded to Morgan Creek Entertainment in 2017) with his partner, Joe Roth.

The company’s first success was "Robin Hood: Prince of Thieves," starring Kevin Costner and making over $400 million worldwide. Since then, they have released numerous box-office hits. Though Robinson remains chairman and CEO, two of his sons run the day-to-day operations.

A Maryland native, Robinson lives in Baltimore with his wife Barbara and their five children, and he commutes to Los Angeles. He attended the University of Maryland.

What is James George Robinson's net worth?: The estimated net worth of James George Robinson is at least $0.00 as of May 2nd, 2022. Mr. Robinson owns 4,702,065 shares of Nymox Pharmaceutical stock worth more than $0 as of April 26th. This net worth evaluation does not reflect any other assets that Mr. Robinson may own. Learn More about James George Robinson's net worth.
How do I contact James George Robinson?: The corporate mailing address for Mr. Robinson and other Nymox Pharmaceutical executives is BAY & DEVEAUX STREETS, NASSAU C5, H4M 2V2. Nymox Pharmaceutical can also be reached via phone at (800) 936-9669 and via email at [email protected]. Learn More on James George Robinson's contact information.
Has James George Robinson been buying or selling shares of Nymox Pharmaceutical?: James George Robinson has not been actively trading shares of Nymox Pharmaceutical within the last three months. Most recently, on Monday, May 2nd, James George Robinson bought 1,151,515 shares of Nymox Pharmaceutical stock. The stock was acquired at an average cost of $1.65 per share, with a total value of $1,899,999.75. Following the completion of the transaction, the director now directly owns 4,702,065 shares of the company's stock, valued at $7,758,407.25. Learn More on James George Robinson's trading history.

James George Robinson Insider Trading History at Nymox Pharmaceutical

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/2/2022	Buy	1,151,515	$1.65	$1,899,999.75	4,702,065
4/21/2021	Buy	13,000	$2.08	$27,040.00	3,512,550
7/9/2019	Buy	7,000	$1.63	$11,410.00	3,503,550
7/5/2019	Buy	9,000	$1.45	$13,050.00	3,496,550
7/3/2019	Buy	8,000	$1.54	$12,320.00	3,487,550
7/1/2019	Buy	9,000	$1.37	$12,330.00	3,472,750
6/27/2019	Buy	9,000	$1.56	$14,040.00	3,453,283
6/25/2019	Buy	9,000	$1.73	$15,570.00	3,441,950
6/20/2019	Buy	9,000	$1.77	$15,930.00	3,434,550
6/18/2019	Buy	9,000	$1.67	$15,030.00	3,408,650
6/13/2019	Buy	8,000	$1.42	$11,360.00	3,408,550
6/11/2019	Buy	9,000	$1.46	$13,140.00	3,391,550
6/5/2019	Buy	11,000	$1.55	$17,050.00	3,362,750
6/3/2019	Buy	9,000	$1.62	$14,580.00	3,362,550
5/30/2019	Buy	8,500	$1.76	$14,960.00	3,335,150
5/28/2019	Buy	9,000	$1.68	$15,120.00	3,335,050
5/24/2019	Buy	8,000	$1.59	$12,720.00	3,318,050
12/12/2018	Buy	6,000	$1.71	$10,260.00	3,305,313
12/10/2018	Buy	7,500	$1.62	$12,150.00	3,294,313
12/6/2018	Buy	1,400	$1.74	$2,436.00	3,279,813
12/4/2018	Buy	7,500	$1.72	$12,900.00	3,278,413
11/29/2018	Buy	7,000	$1.81	$12,670.00	3,265,913
11/27/2018	Buy	8,000	$1.71	$13,680.00	3,258,913
11/20/2018	Buy	6,000	$1.78	$10,680.00	3,244,913
11/16/2018	Buy	6,000	$1.93	$11,580.00	3,235,913
11/13/2018	Buy	7,000	$2.00	$14,000.00	3,229,913
11/9/2018	Buy	13,000	$2.09	$27,170.00	3,210,240
11/7/2018	Buy	363	$2.04	$740.52	3,209,913
11/2/2018	Buy	7,000	$1.98	$13,860.00	3,204,350
10/31/2018	Buy	12,000	$1.79	$21,480.00	3,184,550
10/25/2018	Buy	10,000	$1.62	$16,200.00	3,168,950
10/22/2018	Buy	8,000	$1.67	$13,360.00	13,340
3/26/2018	Buy	8,000	$3.93	$31,440.00	3,159,550
3/20/2018	Buy	8,000	$4.02	$32,160.00	3,152,550
3/15/2018	Buy	8,000	$3.58	$28,640.00	3,144,550
3/9/2018	Buy	8,000	$3.48	$27,840.00	3,136,550
2/21/2018	Buy	6,000	$3.23	$19,380.00	3,123,250
2/16/2018	Buy	7,000	$3.27	$22,890.00
2/12/2018	Buy	8,000	$3.27	$26,160.00	3,107,850
2/8/2018	Buy	10,000	$3.37	$33,700.00	3,091,050
2/2/2018	Buy	5,000	$3.47	$17,350.00	3,090,550
1/18/2018	Buy	3,000	$3.14	$9,420.00	3,085,550
8/3/2017	Buy	10,000	$3.73	$37,300.00	3,077,550
8/2/2017	Buy	5,000	$3.79	$18,950.00	3,077,550
8/1/2017	Buy	15,000	$3.72	$55,800.00	3,062,550
7/7/2017	Buy	11,500	$4.00	$46,000.00	3,046,550
7/6/2017	Buy	3,000	$3.92	$11,760.00	3,046,550
7/5/2017	Buy	5,000	$3.97	$19,850.00	3,046,550
6/28/2017	Buy	8,500	$4.09	$34,765.00	3,040,050
6/26/2017	Buy	15,000	$3.80	$57,000.00	3,027,550
6/21/2017	Buy	15,000	$3.77	$56,550.00	3,008,150
6/20/2017	Buy	5,000	$3.76	$18,800.00	3,008,150
6/19/2017	Buy	5,000	$3.79	$18,950.00	3,008,150
5/30/2017	Buy	54,500	$3.81	$207,645.00	2,957,550
3/8/2017	Buy	50,000	$3.59	$179,500.00	2,906,078
8/10/2016	Buy	500	$2.47	$1,235.00	2,907,550
8/4/2016	Buy	7,000	$3.41	$23,870.00	2,902,550
7/29/2016	Buy	22,500	$3.86	$86,850.00	2,880,050
7/20/2016	Buy	10,000	$3.33	$33,300.00	2,870,050
7/7/2016	Buy	20,000	$3.28	$65,600.00	2,850,050
6/29/2016	Buy	17,500	$3.53	$61,775.00	2,833,050
6/24/2016	Buy	22,500	$2.97	$66,825.00	2,810,050
5/13/2016	Buy	28,010	$2.31	$64,703.10	2,782,550
5/3/2016	Buy	6,990	$2.36	$16,496.40	2,777,050
4/29/2016	Buy	15,000	$2.27	$34,050.00	2,762,550
4/15/2016	Buy	39,500	$2.39	$94,405.00	2,722,550
4/1/2016	Buy	20,500	$2.40	$49,200.00	2,701,050
3/24/2016	Buy	40,000	$2.29	$91,600.00	2,659,050
1/12/2016	Buy	20,000	$2.44	$48,800.00	2,657,550
1/8/2016	Buy	95,000	$2.90	$275,500.00	2,637,550
12/30/2015	Buy	5,000	$3.38	$16,900.00	2,542,550
12/29/2015	Buy	14,000	$3.55	$49,700.00	2,542,550
12/28/2015	Buy	6,000	$3.79	$22,740.00	2,542,550
12/23/2015	Buy	29,854	$3.54	$105,683.16	2,517,550
12/18/2015	Buy	63,334	$3.56	$225,469.04	2,487,696
12/11/2015	Buy	46,812	$3.51	$164,310.12	2,424,362
12/4/2015	Buy	110,000	$3.44	$378,400.00	2,377,550
9/3/2015	Buy	100,000	$2.25	$225,000.00	2,267,550

James George Robinson Buying and Selling Activity at Nymox Pharmaceutical

Nymox Pharmaceutical Company Overview

Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which is in various clinical trials for the treatment of benign prostatic hyperplasia and low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. The company also develops and markets NicAlert for detecting tobacco product usage; and TobacAlert for detecting second-hand smoke exposure. In addition, it develops drugs for the treatment of Alzheimer's disease. Nymox Pharmaceutical Corporation was founded in 1989 and is headquartered in Nassau, the Bahamas.

Today's Range

Now: N/A

50 Day Range

MA: $0.34

$0.19

$0.47

2 Week Range

Now: N/A

Volume

932,700 shs

Average Volume

94,622 shs

Market Capitalization

$18.10 million

P/E Ratio

N/A

Dividend Yield